CLINICAL AND ECONOMICAL ASPECTS OF NOVEL APPROACHES TO THE TREATMENT OF CHRONIC HEART FAILURE DECOMPENSATION

Aim. To study the changes in expenses for the usage of the novel medication serelaxine in treatment of decompensated chronic heart failure.Material and methods. At the core of study — buit-up Mark model that takes into consideration two scenarios of the disease course in patients with decompensated...

Full description

Bibliographic Details
Published in:	Российский кардиологический журнал
Main Authors:	S. K. Zyryanov, G. P. Arutyunov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-03-01
Subjects:	chf decompensation serelaxine pharmacoeconomics
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/302

Similar Items

NEW PROSPECTS IN PHARMACOLOGICAL TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE. EXPERIENCE WITH SERELAXIN. A CLINICAL CASE
by: S. D. Mayanskaya
Published: (2017-12-01)

Organoprotective effects of serelaxin in patients with severe decompensated heart failure
by: Z. D. Kobalava, et al.
Published: (2016-09-01)

SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
by: I. V. Zhirov, et al.
Published: (2015-09-01)

CHRONIC HEART FAILURE IN RUSSIAN FEDERATION: WHAT DO WE KNOW AND WHAT TO DO
by: I. V. Fomin
Published: (2016-08-01)

Improving outpatient care in chronic heart failure
by: S. A. Boytsov, et al.
Published: (2021-08-01)

Strategy of selecting the scales of risk, prognosis, and disease severity in patients with acute decompensated heart failure
by: A. G. Arutyunov
Published: (2013-04-01)

Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2011-04-01)

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)
by: Fiona J. Gifford, et al.
Published: (2020-03-01)

Decompensation of chronic heart failure after COVID-19: a clinical observation
by: Marina V. Moiseeva, et al.
Published: (2023-02-01)

Long-acting relaxin analogues: a novel tool in cardiology
by: Łukasz Wołowiec, et al.
Published: (2025-08-01)

DECOMPENSATED CHRONIC HEART FAILURE: FROM PATHOGENESIS TO PROGNOSIS
by: K. S. Fazulina
Published: (2016-12-01)

Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients
by: Colin J. Petrie, et al.
Published: (2018-10-01)

CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE
by: Zh. D. Kobalava, et al.
Published: (2016-05-01)

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis
by: Yan Lan, et al.
Published: (2024-11-01)

Obesity and Clinical Outcomes of Acute Decompensated Heart Failure
by: Alviyatul Ainin Nuvus, et al.
Published: (2025-01-01)

Prognostic value of renal function in patients with acute decompensation of chronic heart failure
by: I. A. Meray, et al.
Published: (2008-08-01)

Prevalence and clinical significance of iron deficiency in patients with acute decompensated heart failure
by: E. A. Smirnova, et al.
Published: (2023-09-01)

A pre - post study to evaluate the clinical efficacy of levosimendan infusion in acute decompensated heart failure
by: K.P. Aiswarya, et al.
Published: (2025-04-01)

Acute decompensation of heart failure: state of the problem
by: Igor V. Zhirov, et al.
Published: (2022-10-01)

Acute decompensated heart failure in patients with prediabetes: relationship with risk factors and comorbidities
by: N. A. Koziolova, et al.
Published: (2023-04-01)

Risk factors for acute decompensated heart failure in type 2 diabetes patients
by: N. A. Koziolova, et al.
Published: (2020-05-01)

IMMUNE RESPONSE IN DECOMPENSATED CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN
by: E. V. Kruchinkina, et al.
Published: (2018-03-01)

ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE DECOMPENSATED CHRONIC HEART FAILURE
by: M. V. Menzorov, et al.
Published: (2014-07-01)

Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure
by: Sylwia Nawrocka-Millward, et al.
Published: (2021-11-01)

Risk stratification in heart failure decompensation in the community: HEFESTOS score
by: José‐María Verdu‐Rotellar, et al.
Published: (2022-02-01)

Clinical implication of sarcopenia in patients with acute decompensated heart failure: Design and rationale
by: Bingqing Bai, et al.
Published: (2025-02-01)

Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?
by: Igor V. Zhirov, et al.
Published: (2022-01-01)

Aquaretics Use in Acute Decompensated Heart Failure (ADHF) Patients: A Literature Review
by: Norman Sukmadi, et al.
Published: (2022-09-01)

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE
by: Yu. M. Lopatin, et al.
Published: (2015-08-01)

Inferior vena cava diameter in patients with chronic heart failure and chronic kidney disease: a retrospective study
by: Jianan Li, et al.
Published: (2025-01-01)

Hypochloraemia and 30 day readmission rate in patients with acute decompensated heart failure
by: Roman Marchenko, et al.
Published: (2020-06-01)

Possibilities of hyperuricemia correction in acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2025-01-01)

Precipitating factors for acute decompensated heart failure in patients with stable chronic left ventricular systolic dysfunction
by: Gajinder Pal Singh Kaler, et al.
Published: (2018-01-01)

Modern approaches to treatment of patients with decompensated chronic heart failure: the role of inflammation in the pathogenesis of decomposition
by: E. V. Kruchinkina, et al.
Published: (2018-12-01)

CMV Infection Is Directly Related to the Inflammatory Status in Chronic Heart Failure Patients
by: Alejandra García-Torre, et al.
Published: (2021-08-01)

Construction of risk prediction model for hyponatremia in patients with acute decompensated heart failure
by: Huanhuan Gong, et al.
Published: (2023-10-01)

Hyperuricemia and acute decompensation of heart failure: is there a causative link? A review
by: Laura H. Sarieva, et al.
Published: (2024-05-01)

Systems of care for ambulatory management of decompensated heart failure
by: Narotham Badrish, et al.
Published: (2024-02-01)

Digital model for predicting the risk of developing acute decompensated heart failure
by: N. B. Lebedeva, et al.
Published: (2024-07-01)

The course of patients with Chagas heart disease during episodes of decompensated heart failure
by: Victor Sarli Issa, et al.
Published: (2021-04-01)